Related Experiment Video
Updated: Aug 6, 2026

A Screening Method for Identification of Heterochromatin-Promoting Drugs Using Drosophila
Published on: March 12, 2020
JAK signaling globally counteracts heterochromatic gene silencing
Song Shi1, Healani C Calhoun, Fan Xia
1Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, New York 14642, USA.
Abstract:
The JAK/STAT pathway has pleiotropic roles in animal development, and its aberrant activation is implicated in multiple human cancers. JAK/STAT signaling effects have been attributed largely to direct transcriptional regulation by STAT of specific target genes that promote tumor cell proliferation or survival. We show here in a Drosophila melanogaster hematopoietic tumor model, however, that JAK overactivation globally disrupts heterochromatic gene silencing, an epigenetic tumor suppressive mechanism. This disruption allows derepression of genes that are not direct targets of STAT, as evidenced by suppression of heterochromatin-mediated position effect variegation. Moreover, mutations in the genes encoding heterochromatin components heterochromatin protein 1 (HP1) and Su(var)3-9 enhance tumorigenesis induced by an oncogenic JAK kinase without affecting JAK/STAT signaling. Consistently, JAK loss of function enhances heterochromatic gene silencing, whereas overexpressing HP1 suppresses oncogenic JAK-induced tumors. These results demonstrate that the JAK/STAT pathway regulates cellular epigenetic status and that globally disrupting heterochromatin-mediated tumor suppression is essential for tumorigenesis induced by JAK overactivation.
Insights
Janus kinase/ யSTAT pathway overactivation disrupts epigenetic gene silencing, promoting cancer. This study reveals JAK/STAT signaling impacts heterochromatin, essential for tumor suppression.
Area of Science:
- Epigenetics
- Molecular Biology
- Cancer Research
Background:
- The Janus Kinase/ யSTAT (JAK/STAT) pathway is crucial for animal development and implicated in human cancers.
- JAK/STAT signaling is traditionally understood to drive tumorigenesis via direct transcriptional regulation of target genes.
Purpose of the Study:
- To investigate the broader impact of JAK/STAT signaling on epigenetic mechanisms in a Drosophila melanogaster hematopoietic tumor model.
- To determine if JAK overactivation affects heterochromatic gene silencing, a known tumor suppressive mechanism.
Main Methods:
- Utilized a Drosophila melanogaster hematopoietic tumor model with JAK overactivation.
- Assessed the effects of JAK overactivation on heterochromatic gene silencing and position effect variegation.
- Investigated the role of heterochromatin components, including heterochromatin protein 1 (HP1) and Su(var)3-9, in JAK-driven tumorigenesis.
Main Results:
- JAK overactivation was found to globally disrupt heterochromatic gene silencing, an epigenetic tumor suppressive mechanism.
- This disruption led to the derepression of genes not directly targeted by STAT.
- Mutations in HP1 and Su(var)3-9 enhanced tumorigenesis, while JAK loss of function enhanced heterochromatic silencing.
Conclusions:
- The JAK/STAT pathway regulates the cellular epigenetic status.
- Global disruption of heterochromatin-mediated tumor suppression is critical for tumorigenesis driven by JAK overactivation.
- This provides a new perspective on the role of epigenetic regulation in JAK/STAT pathway-associated cancers.
More Related Videos
10:28Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
10:28Analysis of Transgenerational Epigenetic Inheritance in C. elegans Using a Fluorescent Reporter and Chromatin Immunoprecipitation (ChIP)
Published on: May 5, 2023
Related Concept Videos
Position-effect Variegation
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Heterochromatin
Constitutive heterochromatin: It is a highly compact region of chromatin that is mostly concentrated in the centromere and telomere. Unlike euchromatin, the amino acid at 9th...